A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone

by Yiyi Chen, William L Redmond, Tomasz M Beer, Julie N Graff, Joshi J Alumkal, Rachel E Slottke, George V Thomas, Reid F Thompson, Mary A Wood, Emile Latour, Raymond C Bergan, Amy E Moran
Published 2020-07-01

Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation Therapy

by Julie N. Graff, Julie N. Graff, Mark N. Stein, Rishi Surana, Luai Al Rabadi, Luai Al Rabadi, Eric Liu, Lawrence Fong, Shawna Bailey, Emile Latour, Timothy A. Newby, Amy E. Moran, Tomasz M. Beer
Published 2020-08-01